| Factor Information | |
|---|---|
| Data ID | 2487 |
| Factor | AoV (mm) |
| Description | N/A |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | Treatment |
| Objective | To identify prenatal echocardiographic markers that could predict the need for neonatal intervention in fetuses with right ventricular outflow tract obstruction |
| p Value | 0.037 |
| Conclusion | Analysis of the pulmonary outflow tract and ductus arteriosus flow in the fetus with complex congenital heart disease can aid in identifying those that will require a neonatal intervention to augment pulmonary blood flow. This has important implications for the planning of delivery strategies. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 604 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
| Reference | |
|---|---|
| PMID | 22605656 |
| Year | 2012 |
| Title | Pulmonary outflow tract obstruction in fetuses with complex congenital heart disease: predicting the need for neonatal intervention. |
| Sample | ||
|---|---|---|
| Population | fetus | |
| Source | N/A | |
| Region | Philadelphia, USA | |
| Method | Echocardiograms | |
| Race | North American | |
| Disease History | North American | |
| Treatment History | N/A | |
| Group | Abnormal DA(ductus arteriosus) flow(Treatment) | Normal DA(ductus arteriosus) flow(Control) |
| Number | 24 | 17 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 8.3±0.56 | 7.7±1.0 |
